# Top 50 Biotechnology VC (Venture Capital) Funds in June 2026

| Investor | Relevant Deals | Geography | Stage | Focus |
| --- | --- | --- | --- | --- |
| SOSV | 257 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software |
| ARCH Venture Partners | 139 | United States, China, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| OrbiMed | 117 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Medical |
| Alexandria Venture Investments | 109 | United States, Canada, France | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics |
| Sofinnova Partners | 107 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical |
| Novo Holdings | 97 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical |
| F-Prime | 83 | United States, United Kingdom, China | Series A, Series B, Series C | Health Care, Biotechnology, Medical |
| Qiming Venture Partners | 83 | China, United States, Hong Kong | Series B, Series A, Series C | Health Care, Biotechnology, Medical |
| Versant Ventures | 83 | United States, Switzerland, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Medical |
| Atlas Venture | 79 | United States, United Kingdom, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| Bpifrance | 78 | France, United States, Switzerland | Seed, Series A | Software, Information Technology, Health Care |
| New Enterprise Associates | 76 | United States, India, United Kingdom | Series A, Series B, Series C | Software, Health Care, Biotechnology |
| RA Capital Management | 74 | United States, United Kingdom, Canada | Series B, Series C, Post-IPO Equity | Biotechnology, Health Care, Therapeutics |
| Khosla Ventures | 74 | United States, India, United Kingdom | Series A, Series B, Seed | Software, Artificial Intelligence, Health Care |
| Polaris Partners | 70 | United States, Ireland, Singapore | Series B, Series A, Series C | Biotechnology, Health Care, Medical |
| HTGF (High-Tech Gruenderfonds) | 67 | Germany, Switzerland, United States | Seed, Series A | Software, Biotechnology, Information Technology |
| M Ventures | 67 | United States, United Kingdom, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics |
| Novartis Venture Fund | 66 | United States, Switzerland, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics |
| 5AM Ventures | 65 | United States, Switzerland, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| MPM Capital | 65 | United States, Canada, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Pharmaceutical |
| Third Rock Ventures | 62 | United States | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| Innova Memphis | 62 | United States, Argentina, United Kingdom | Seed, Pre-Seed | Health Care, Medical, Medical Device |
| UK Innovation & Science Seed Fund | 58 | United Kingdom, United States | Seed, Series A | Biotechnology, Health Care, Medical |
| Lilly Asia Ventures | 56 | China, United States, Hong Kong | Series A, Series B, Series C | Biotechnology, Health Care, Medical |
| HSG | 56 | China, United States, Hong Kong | Series A, Series B, Series C | Health Care, Biotechnology, Software |
| Google Ventures | 56 | United States, United Kingdom, Israel | Series A, Series B, Seed | Software, Health Care, Biotechnology |
| Alumni Ventures | 55 | United States, United Kingdom, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology |
| Canaan Partners | 53 | United States, United Kingdom, Israel | Series A, Series B, Series C | Software, Biotechnology, Health Care |
| Boehringer Ingelheim Venture Fund | 52 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics |
| Andreessen Horowitz | 52 | United States, United Kingdom, Brazil | Series A, Seed, Series B | Software, Information Technology, Artificial Intelligence |
| Lux Capital | 51 | United States, United Kingdom, Canada | Series A, Seed, Series B | Software, Artificial Intelligence, Health Care |
| BioAdvance | 51 | United States, Canada | Seed, Series A | Biotechnology, Health Care, Medical |
| Pfizer Venture Investments | 51 | United States, United Kingdom, Switzerland | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics |
| Forbion Capital Partners | 50 | United States, United Kingdom, The Netherlands | Series B, Series A, Series C | Biotechnology, Health Care, Medical |
| SR One | 49 | United States, United Kingdom, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| Fifty Years | 49 | United States, Germany, Canada | Seed, Series A, Series B | Biotechnology, Health Care, Artificial Intelligence |
| Seventure Partners | 48 | France, United States, Germany | Series A, Series B | Biotechnology, Software, Health Care |
| Parkwalk Advisors | 47 | United Kingdom, United States, Philippines | Seed, Series A, Series B | Biotechnology, Health Care, Software |
| DCVC | 47 | United States, Canada, United Kingdom | Seed, Series A, Series B | Software, Artificial Intelligence, Machine Learning |
| Eli Lilly | 47 | United States, United Kingdom, Canada | Series A, Series B | Biotechnology, Health Care, Medical |
| Takeda Ventures | 46 | United States, United Kingdom, Israel | Series A, Series B | Biotechnology, Health Care, Therapeutics |
| Scottish Enterprise | 46 | United Kingdom, United States, Japan | Seed, Grant | Biotechnology, Software, Health Care |
| The Column Group | 46 | United States | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| KdT Ventures | 46 | United States, India, Canada | Seed, Series A, Series B | Biotechnology, Health Care, Medical |
| Sofinnova Investments | 46 | United States, France, Switzerland | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical |
| Omega Funds | 44 | United States, Switzerland, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| EQT Life Sciences | 43 | United States, The Netherlands, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics |
| Casdin Capital | 42 | United States, China, France | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics |
| HealthCap | 42 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical |
| Oxford Science Enterprises | 42 | United Kingdom, United States, Finland | Seed, Series A, Series B | Health Care, Biotechnology, Software |